Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.710
+0.140 (5.45%)
Aug 5, 2025, 12:03 PM - Market open
Lisata Therapeutics Revenue
Lisata Therapeutics had revenue of $1.00M in the twelve months ending March 31, 2025. In the year 2024, Lisata Therapeutics had annual revenue of $1.00M.
Revenue (ttm)
$1.00M
Revenue Growth
n/a
P/S Ratio
21.60
Revenue / Employee
$38,462
Employees
26
Market Cap
23.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.00M | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
LSTA News
- 5 days ago - Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025 - GlobeNewsWire
- 19 days ago - Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update - GlobeNewsWire
- 21 days ago - Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide - GlobeNewsWire
- 7 weeks ago - Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development - GlobeNewsWire
- 7 weeks ago - Lisata Therapeutics to Present at the 2025 BIO International Convention - GlobeNewsWire
- 3 months ago - Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025 - GlobeNewsWire